BCL10, BCL10 immune signaling adaptor, BCL2, BCL2 apoptosis regulator, CARD11, CBM, CR2, EBNA, EBV, Epstein Barr nuclear antigen, Epstein-Barr virus, FCGR3A, Fc gamma receptor IIIa, GLILD, IKB kinase, IKBKB, IL2RA, MALT1, MALT1 paracaspase, MS4A1, MTOR, MYC, NCAM1, NFKB, NK, PBMCs, PTPRC, SELL, T cell receptor, Tregs, bHLH, caspase recruitment domain family member 11, complement C3d receptor 2, granulomatous-lymphocytic interstitial lung disease, hyperplasia, immune dysregulation, inhibitor of nuclear factor kappa B kinase subunit beta, interleukin 2 receptor subunit alpha, mechanistic target of rapamycin kinase, membrane spanning 4-domain A1, natural killer, neural cell adhesion molecule 1, nuclear factor kappa B, oncogene, patient, peripheral blood mononuclear cells, protein tyrosine phosphatase receptor type C, rapamycin, regulatory T cells, selectin L, tyrosine